P1192: ANTI-PD-1 ANTIBODY (TISLELIZUMAB) COMBINED WITH R-CHOP FOR THE TREATMENT OF PREVIOUSLY UNTREATED PRIMARY MEDIASTINAL B-CELL LYMPHOMA: A PROSPENTIVE PHASE II STUDY
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000971664.08620.74 |
| _version_ | 1797279939061350400 |
|---|---|
| author | Wu Mei Zhu Lin LI Shan Tu Erde Jia Erbao Wang Shanshan Liang Xiao Hu Xin Guo LI A Dili Abulikemujiang Maimaitirexiati Xianmusiya Ren Ruirui Wen Shujuan |
| author_facet | Wu Mei Zhu Lin LI Shan Tu Erde Jia Erbao Wang Shanshan Liang Xiao Hu Xin Guo LI A Dili Abulikemujiang Maimaitirexiati Xianmusiya Ren Ruirui Wen Shujuan |
| author_sort | Wu Mei |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:34:05Z |
| format | Article |
| id | doaj.art-04f07fe38fc749e49f9d042cb8f641d4 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:34:05Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-04f07fe38fc749e49f9d042cb8f641d42024-03-03T10:04:28ZengWileyHemaSphere2572-92412023-08-017e086207410.1097/01.HS9.0000971664.08620.74202308003-01090P1192: ANTI-PD-1 ANTIBODY (TISLELIZUMAB) COMBINED WITH R-CHOP FOR THE TREATMENT OF PREVIOUSLY UNTREATED PRIMARY MEDIASTINAL B-CELL LYMPHOMA: A PROSPENTIVE PHASE II STUDYWu Mei0Zhu Lin1LI Shan2Tu Erde Jia Erbao3Wang Shanshan4Liang Xiao5Hu Xin6Guo LI7A Dili Abulikemujiang8Maimaitirexiati Xianmusiya9Ren Ruirui10Wen Shujuan111 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, Chinahttp://journals.lww.com/10.1097/01.HS9.0000971664.08620.74 |
| spellingShingle | Wu Mei Zhu Lin LI Shan Tu Erde Jia Erbao Wang Shanshan Liang Xiao Hu Xin Guo LI A Dili Abulikemujiang Maimaitirexiati Xianmusiya Ren Ruirui Wen Shujuan P1192: ANTI-PD-1 ANTIBODY (TISLELIZUMAB) COMBINED WITH R-CHOP FOR THE TREATMENT OF PREVIOUSLY UNTREATED PRIMARY MEDIASTINAL B-CELL LYMPHOMA: A PROSPENTIVE PHASE II STUDY HemaSphere |
| title | P1192: ANTI-PD-1 ANTIBODY (TISLELIZUMAB) COMBINED WITH R-CHOP FOR THE TREATMENT OF PREVIOUSLY UNTREATED PRIMARY MEDIASTINAL B-CELL LYMPHOMA: A PROSPENTIVE PHASE II STUDY |
| title_full | P1192: ANTI-PD-1 ANTIBODY (TISLELIZUMAB) COMBINED WITH R-CHOP FOR THE TREATMENT OF PREVIOUSLY UNTREATED PRIMARY MEDIASTINAL B-CELL LYMPHOMA: A PROSPENTIVE PHASE II STUDY |
| title_fullStr | P1192: ANTI-PD-1 ANTIBODY (TISLELIZUMAB) COMBINED WITH R-CHOP FOR THE TREATMENT OF PREVIOUSLY UNTREATED PRIMARY MEDIASTINAL B-CELL LYMPHOMA: A PROSPENTIVE PHASE II STUDY |
| title_full_unstemmed | P1192: ANTI-PD-1 ANTIBODY (TISLELIZUMAB) COMBINED WITH R-CHOP FOR THE TREATMENT OF PREVIOUSLY UNTREATED PRIMARY MEDIASTINAL B-CELL LYMPHOMA: A PROSPENTIVE PHASE II STUDY |
| title_short | P1192: ANTI-PD-1 ANTIBODY (TISLELIZUMAB) COMBINED WITH R-CHOP FOR THE TREATMENT OF PREVIOUSLY UNTREATED PRIMARY MEDIASTINAL B-CELL LYMPHOMA: A PROSPENTIVE PHASE II STUDY |
| title_sort | p1192 anti pd 1 antibody tislelizumab combined with r chop for the treatment of previously untreated primary mediastinal b cell lymphoma a prospentive phase ii study |
| url | http://journals.lww.com/10.1097/01.HS9.0000971664.08620.74 |
| work_keys_str_mv | AT wumei p1192antipd1antibodytislelizumabcombinedwithrchopforthetreatmentofpreviouslyuntreatedprimarymediastinalbcelllymphomaaprospentivephaseiistudy AT zhulin p1192antipd1antibodytislelizumabcombinedwithrchopforthetreatmentofpreviouslyuntreatedprimarymediastinalbcelllymphomaaprospentivephaseiistudy AT lishan p1192antipd1antibodytislelizumabcombinedwithrchopforthetreatmentofpreviouslyuntreatedprimarymediastinalbcelllymphomaaprospentivephaseiistudy AT tuerdejiaerbao p1192antipd1antibodytislelizumabcombinedwithrchopforthetreatmentofpreviouslyuntreatedprimarymediastinalbcelllymphomaaprospentivephaseiistudy AT wangshanshan p1192antipd1antibodytislelizumabcombinedwithrchopforthetreatmentofpreviouslyuntreatedprimarymediastinalbcelllymphomaaprospentivephaseiistudy AT liangxiao p1192antipd1antibodytislelizumabcombinedwithrchopforthetreatmentofpreviouslyuntreatedprimarymediastinalbcelllymphomaaprospentivephaseiistudy AT huxin p1192antipd1antibodytislelizumabcombinedwithrchopforthetreatmentofpreviouslyuntreatedprimarymediastinalbcelllymphomaaprospentivephaseiistudy AT guoli p1192antipd1antibodytislelizumabcombinedwithrchopforthetreatmentofpreviouslyuntreatedprimarymediastinalbcelllymphomaaprospentivephaseiistudy AT adiliabulikemujiang p1192antipd1antibodytislelizumabcombinedwithrchopforthetreatmentofpreviouslyuntreatedprimarymediastinalbcelllymphomaaprospentivephaseiistudy AT maimaitirexiatixianmusiya p1192antipd1antibodytislelizumabcombinedwithrchopforthetreatmentofpreviouslyuntreatedprimarymediastinalbcelllymphomaaprospentivephaseiistudy AT renruirui p1192antipd1antibodytislelizumabcombinedwithrchopforthetreatmentofpreviouslyuntreatedprimarymediastinalbcelllymphomaaprospentivephaseiistudy AT wenshujuan p1192antipd1antibodytislelizumabcombinedwithrchopforthetreatmentofpreviouslyuntreatedprimarymediastinalbcelllymphomaaprospentivephaseiistudy |